Онкогематология (Jul 2022)

Hemophagocytic syndrome associated with leishmaniasis: case report

  • V. G. Potapenko,
  • M. M. Antonov,
  • N. V. Vinogradova,
  • E. V. Doguzhieva,
  • V. E. Karev,
  • E. S. Karamurzin,
  • G. V. Kachenya,
  • A. V. Klimovich,
  • S. S. Kozlov,
  • Yu. A. Krivolapov,
  • S. V. Lapin,
  • M. Yu. Pervakova,
  • N. A. Potikhonova,
  • I. P. Fedunyak,
  • N. V. Medvedeva

DOI
https://doi.org/10.17650/1818-8346-2022-17-3-89-97
Journal volume & issue
Vol. 17, no. 3
pp. 89 – 97

Abstract

Read online

Secondary hemophagocytic syndrome (sHLH) is a hyperinflammatory reaction which manifests with fever, cytopenia and organ damage. possible causes of sHLH include leishmaniasis. The article describes a clinical case of sHLH in patient with visceral leishmaniasis. A female 30 years old developed hectic daily fever up to 40 °C, pancytopenia, cytolytic syndrome, hyperferritin- and hypertriglyceridemia, immunoglobulin G to capsid antigens of the Epstein-Barr virus, enlarged liver and spleen a one and a half month after returning from Spain. based on the HLH-2004 and H-Score criteria, a sHLH was diagnosed, presumably associated with the Epstein-Barr virus. Immunosuppressive treatment with dexamethasone, cyclosporin-A and etoposide was started under the HLH-2004 program. Apyrexia, reduction of splenomegaly and resolution of cytolysis were achieved. The fever resumed 20 days after the start of chemotherapy, the spleen enlarged again, and therefore a diagnostic splenectomy was performed. Morphological analysis of the removed spleen revealed leishmania. After amphotericin-B therapy, the patient recovered. Chemotherapy of sHLH led to a temporary improvement for a period sufficient to verify the diagnosis and conducting of successful treatment.

Keywords